Phase I single-dose trial of CORT 108297 in volunteers.

Trial Profile

Phase I single-dose trial of CORT 108297 in volunteers.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Feb 2010

At a glance

  • Drugs CORT 108297 (Primary)
  • Indications Weight gain
  • Focus Adverse reactions
  • Sponsors Corcept Therapeutics
  • Most Recent Events

    • 26 Feb 2010 Status changed from planning to recruiting.
    • 26 Feb 2010 Estimated study completion date is in the first half of 2010, according to a Corcept Therapeutics media release.
    • 07 Jan 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top